TOF LVOTO CA Others Total % (N)
Participants --- 5.2 (31) 54.8 (329) 18.3 (110) 21.7 (130) 100 (600)
Participants’ Gender Female 58.1 (18) 47.4 (156) 55.5 (61) 54.6 (71) 51.0 (306)
  Male 41.9 (13) 52.6 (173) 44.5 (49) 45.4 (59)  49.0 (294)
Affected Children (AC) --- 5.8 (10) 64.5 (111) 14.0 (24) 15.7 (27) 100 (172)
AC’S Gender Female 60.0 (6) 34.2 (38) 50.0 (12) 40.7 (11) 39.0 (67)
  Male 40.0 (4) 65.8 (73) 50.0 (12) 59.3 (16) 61.0 (105)
Consent Mother 38.5 (5) 73.7 (115) 59.3 (32) 18.6 (8) 70.3 (187)
  Father 61.5 (8) 26.3 (41) 40.7 (22) 81.4 (35) 29.7 (79)
Lineage Maternal 100 (3) 44.1 (15) 90.5 (19) 64.7 (22) 64.1 (59)
  Paternal 0() 55.9 (19) 9.5 (2) 35.3 (12) 35.9 (33)
Cell Lines 100 (19/19) 70.6 (113/160) 81.7 (49/60) 78.8 (63/80) 76.5 (244/319)  
Table 3: CHD-grouping – Gender of research participants and respondents, lineage and consent to cell lines